Publications by authors named "M Alsina"

Claim this Profile
D
Dermatologic Adverse Effects With Elranatamab Mimicking Talquetamab.
M Bakri Hammami, Sean P Haney, Danny DeAvila, Julia Fadul, Christine E Simonelli, Melissa Alsina

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study.
J-P Metges, K Kato, J-M Sun, L Shen, P C Enzinger, M Alsina

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma.
Francesco Maura, Ciara L Freeman, Kylee H Maclachlan, Marta Larrayoz Ilundain, Bachisio Ziccheddu, Melissa Alsina

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease.
Ziad Abuhelwa, Fnu Amisha, Wenyi Fan, Gabriel De Avila, Doris K Hansen, Melissa Alsina

Front Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysis.
Alberto Giovanni Leone, Fausto Petrelli, Samuel J Klempner, Elizabeth C Smyth, Raghav Sundar, Maria Alsina

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis